SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Spero Therapeutics Names Regulatory and Corporate Development Leaders; COO to Retire

Spero appointed Amy Rock as chief regulatory and quality officer and Dae Gon Ha as SVP of corporate development. COO Timothy Keutzer will retire effective Dec. 31, 2026.

SPRO

Related stories